@article{8fe432e5df55454a923c2e9f0a3217f8,
title = "Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry",
abstract = "To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic lupus erythematosus (SLE) refractory to standard therapy in the clinical practice setting.",
keywords = "Adult, Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, Dose-Response Relationship, Drug, Drug Monitoring, Drug Resistance, Female, Humans, Immunosuppression, Italy, Lupus Erythematosus, Systemic, Male, Middle Aged, Off-Label Use, Remission Induction, Rituximab, Severity of Illness Index, Treatment Outcome, Adult, Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, Dose-Response Relationship, Drug, Drug Monitoring, Drug Resistance, Female, Humans, Immunosuppression, Italy, Lupus Erythematosus, Systemic, Male, Middle Aged, Off-Label Use, Remission Induction, Rituximab, Severity of Illness Index, Treatment Outcome",
author = "Luca Iaccarino and Elena Bartoloni and Linda Carli and Fulvia Ceccarelli and Fabrizio Conti and {De Vita}, Salvatore and Gianfranco Ferraccioli and Mauro Galeazzi and Mariele Gatto and Roberto Gerli and Marcello Govoni and Elisa Gremese and Annamaria Iuliano and Elena Mansutti and Gabriella Moroni and Marta Mosca and Cecilia Nalli and Carla Naretto and Melissa Padovan and Lavinia Palma and Francesca Raffiotta and Dario Roccatello and Angela Tincani and Guido Valesini and Margherita Zen and Andrea Doria",
year = "2015",
language = "English",
volume = "33",
pages = "449--456",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology:Via S Maria 31, I 56126 Pisa Italy:011 39 050 40124, EMAIL: info@clinexprhematol.org, INTERNET: http://www.clinexprhematol.org, Fax: 011 39 050 502299",
}